Riskpilot← Back to searchSign inGet full accessBASILEA PHARMACEUTICALS A/S
A/SDissolvedCVR 30723732Havneholmen 29Wholesale of pharmaceutical and medical goods · NACE 4646Est. 20071 employees
Revenue 2016
DKK -36K
-41% vs 2015
EBITDA margin
100.0%
+41% vs 2015
Equity ratio
99.6%
Financial strength
Net profit 2016
DKK 16K
+152% vs 2015
| Revenue | DKK -36K | -41% |
| EBITDA | DKK -36K | +41% |
| Net profit | DKK 16K | +152% |
| Total assets | DKK 4,2M | -6% |
| Equity | DKK 4,2M | +0% |
| Employees | — | — |
Legal name
BASILEA PHARMACEUTICALS A/S
CVR number
30723732
Legal form
Aktieselskab
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
10. juli 2007
Share capital
DKK 3.050.000
Employees
1
VAT registered
No
Audit selected
No
Last report
2016-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af to bestyrelsesmedlemmer i forening eller af et bestyrelsesmedlem med en direktør.
Address
Havneholmen 29
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|
| Revenue | 3.865 | -318 | -68 | -60 | -35 |
| Staff expenses | -2.631 | -10 | -0 | -0 | -0 |
| EBITDA | 1.233 | -328 | -68 | -60 | -35 |
| Depreciation & amort. | -13 | -0 | -0 | -0 | -0 |
| EBIT | 1.220 | -328 | -68 | -60 | -35 |
| Net financials | 28 | 87 | 53 | 30 | 51 |
| Profit before tax | 1.248 | -241 | -14 | -31 | 16 |
| Tax | 328 | 33 | -0 | -0 | -0 |
| Net profit | 920 | -274 | -14 | -31 | 16 |
| Item | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|
| Total assets | 4.678 | 4.578 | 4.533 | 4.502 | 4.215 |
| Equity | 4.503 | 4.229 | 4.215 | 4.184 | 4.200 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 175 | 349 | 318 | 318 | 15 |
| Total debt | 175 | 349 | 318 | 318 | 15 |
EBITDA margin
-3550000.0%
This company
15.8%
Market median
-22468454% vs market
20122016
Equity ratio
99.6%
This company
38.2%
Market median
+161% vs market
20122016
Return on equity
0.4%
This company
18.4%
Market median
-98% vs market
20122016
Net profit margin
1596700.0%
This company
8.1%
Market median
+19712246% vs market
20122016
Asset turnover
-0.01×
This company
1.12×
Market median
-101% vs market
20122016
Debt / equity
0.00×
This company
0.62×
Market median
+100% vs market
20122016
- Annual report 2016Filed via CVR / Virk · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via CVR / Virk · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via CVR / Virk · Period 2014-01-01 – 2014-12-31
- Annual report 2013Filed via CVR / Virk · Period 2013-01-01 – 2013-12-31
- Annual report 2012Filed via CVR / Virk · Period 2012-01-01 – 2012-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
AW Chief Executive Officer | Chief Executive Officer | 2015 | — | — |
BP Founder | Founder | 2007 | — | — |
DS Management | Management | 2013 | — | — |
JE Management | Management | 2012 | — | — |
UV Management | Management | 2007 | — | — |
KA Management | Management | 2007 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2011 | — | — | |
| Board of Directors | 2012 | — | — | |
| Board of Directors | 2007 | — | — | |
| Chairman | 2013 | — | — | |
| Chairman | 2008 | — | — | |
| Board of Directors | 2012 | — | — | |
| Board of Directors | 2008 | — | — | |
| Board of Directors | 2014 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 100.0% | 100.0% | 2009 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of BASILEA PHARMACEUTICALS A/S also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Arne Wiechmann | Chief Executive Officer | 0 companies |
| Basilea Pharmaceutica AG | Founder | 0 companies |
| Donato Spota | Management | 0 companies |
| Joachim Emil Blatter | Management | 0 companies |
| Ulrich Vilhelm Eisenring | Management | 0 companies |
| Kim Arvid Nielsen | Management | 0 companies |
| Ole Nygaard Pedersen | Board of Directors | 0 companies |
| Elizabeth Rozek | Board of Directors | 0 companies |
| Donato Spota | Board of Directors | 0 companies |
| Patrick Geiser | Chairman | 0 companies |
| Majk Rütschmann | Chairman | 0 companies |
| Daniel Feuz | Board of Directors | 0 companies |
| Flemming Wendelboe Maunsbach | Board of Directors | 0 companies |
| Markus Jäger | Board of Directors | 0 companies |